Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. (NGP), was founded in 2023. Our mission is to bridge the gap between millennial-long Traditional Chinese Medicine (TCM) culture and modern global healthcare demands. As a pivotal branch of the NGP group, we represent one of the only six pilot manufacturers approved by the Chinese government for the formulation and production of TCM granules.
By leveraging proprietary Smart TCM Pharmacy systems and rigorous scientific standards, we have transformed the way herbal medicine is manufactured, exported, and applied in clinical settings across North America, Europe, and Asia.
The global market for Traditional Chinese Medicine is experiencing an unprecedented CAGR as consumers shift toward holistic and preventive healthcare. Beyond traditional markets in Asia, the demand in the United States and Europe is expanding into sports medicine, integrative oncology, and chronic pain management.
Modern TCM practices have moved beyond raw decoctions. The industry trend is focused on standardized herb granules and concentrated capsules. These formats ensure dosage accuracy, eliminate the need for laborious boiling, and allow for easier integration into Western medical environments.
Digitization is the new frontier. From AI-driven soil monitoring at GAP planting bases to automated dispensing systems in "Smart Pharmacies," technology ensures that every batch of medicine is traceable, potent, and safe from heavy metals or pesticides.
Global medical institutions and herbal extract wholesalers require a partner that provides more than just raw materials. They need:
Our TCM granules are used in diverse local contexts:
Workshops built to GAP standards with exclusive extraction processes.
Compliance is our priority. Every product comes from certified sourcing channels.
A "National Enterprise Technology Center" with over two decades of innovation.
Dedicated B2B supply chain solutions tailored for practitioners globally.
NGP has pioneered the “New Circular Economy of Traditional Chinese Medicine.” This innovative model integrates the entire industrial chain:
With assets exceeding 30 billion RMB and a footprint expanding through Jiangxi, Yunnan, and Chongqing, we are not just a manufacturer; we are the vanguard of TCM sustainability.
If you are interested in our products or wish to establish a long-term pharmaceutical supply chain partnership, we are here to provide comprehensive solutions for your clinic or medical institution.
Inquiry Now & Contact Us